Skip to content
1887
Volume 26, Issue 1
  • ISSN: 0032-1400

Abstract

Work is continuing in a number of institutions to develop a second generation of anti-tumour drugs, based upon complex compounds of platinum, that will offer greater selectivity together with a reduction in toxic side-effects. During the course of a three-day meeting held in Bologna in Italy in September, the Ninth International Symposium on the Biological Characterisation of Human Tumours, a paper was presented by Dr. M. J. Cleare of the Johnson Matthey Group Research Centre. A summary of his talk is given here.

Loading

Article metrics loading...

/content/journals/10.1595/003214082X2613333
1982-01-01
2024-03-04
Loading full text...

Full text loading...

/deliver/fulltext/pmr/26/1/pmr0026-0033.html?itemId=/content/journals/10.1595/003214082X2613333&mimeType=html&fmt=ahah
http://instance.metastore.ingenta.com/content/journals/10.1595/003214082X2613333
Loading
  • Article Type: Research Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error